Get the Stockscreener App
47.50
2.28%
-1.11
After Hours:
48.61
1.11
+2.34%
Caredx Inc stock is traded at $47.50, with a volume of 769.37K.
It is down -2.28% in the last 24 hours and up +27.89% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$48.61
Open:
$48.3
24h Volume:
769.37K
Relative Volume:
0.74
Market Cap:
$2.46B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-308.24
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
+2.41%
1M Performance:
+27.89%
6M Performance:
+146.75%
1Y Performance:
+266.23%
1-Day Range:
$46.92
$48.51
1-Week Range:
$44.80
$48.72
52-Week Range:
$12.37
$49.76
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
47.50 | 2.43B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
628.74 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.11 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
327.72 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
559.51 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
153.43 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Is CareDx Inc (CDNA) Overvalued After 3.5% Rally? GF Value Says - GuruFocus
CareDx Inc (1K9) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Ron Baron Trims CareDx Inc (CDNA) Stake -- Shares Trade 86% Above GF Value - GuruFocus
Price to book forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
CareDx (NASDAQ:CDNA) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
CareDx (CDNA) Q2 2026 Results: EPS Exceeds Its Estimate in the Latest Reading; Stock Move: The Stock Loses 0.43% in the Current UpdateAnalyst Consensus Shift - vinanet.vn
Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar - Yahoo Finance
CareDx Market Sentiment - Benzinga France
Price to book forward of CareDx, Inc. – DUS:1K9 - TradingView
CareDx (NASDAQ: CDNA) insider lines up $423K stock sale - Stock Titan
CareDx Inc (CDNA) Shares Fall 4.3% -- What GF Score of 67 Tells Investors - GuruFocus
CareDx (CDNA) insider Peter Maag files to sell 7,000 shares after large prior sales - Stock Titan
Baron group trims CareDx (CDNA) stake to 3.75% in latest 13G/A - Stock Titan
CareDx Inc Earnings Call Highlights Growth And Risks - TipRanks
CDNA (CDNA) insider Peter Maag discloses 7,000-share planned sale and recent trades - Stock Titan
Does CareDx’s Profit Jump And Higher 2026 Outlook Change The Bull Case For CDNA? - Sahm
CareDx (CDNA) insider Peter Maag files to sell 7,000 NASDAQ-listed shares - Stock Titan
Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA) - Yahoo Finance
CareDx Stock Is Up 300% Over the Past Year. Here’s How Much Upside Is Left. - webull.com
CDNA (CDNA) insider Peter Maag files Form 144 for 6,902-share stock sale - Stock Titan
Arthur Torres (CDNA) files Form 144 to sell 4,200 shares of common stock - Stock Titan
This Insider Has Just Sold Shares In CareDx - webull.com
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - webull.com
Have Insiders Sold CareDx Shares Recently? - Moomoo
Zacks Research Upgrades CareDx (NASDAQ:CDNA) to Strong-Buy - MarketBeat
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Finviz
CareDx (CDNA): Neil Gagnon and Gagnon entities report 4.4% ownership stake - Stock Titan
CareDx (NASDAQ: CDNA) insider Peter Maag plans 27,332-share stock sale after option exercise - Stock Titan
CareDx Inc (CDNA) Stock News Today - TradingKey
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
State Street (CDNA holder) discloses 2.47M CareDx shares under shared control - Stock Titan
CareDx (NASDAQ:CDNA) Is Posting Healthy Earnings, But It Is Not All Good News - Moomoo
CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside - DirectorsTalk Interviews
Janus Henderson Group PLC Has $5.50 Million Stock Position in CareDx, Inc. $CDNA - MarketBeat
CareDx Inc (CDNA) Insider Sell: Secretary and General Counsel Je - GuruFocus
CareDx (NASDAQ:CDNA) Director Sells $925,600.00 in Stock - MarketBeat
Christine Cournoyer Sells 16,000 Shares of CareDx (NASDAQ:CDNA) Stock - MarketBeat
CareDx, Inc. (CDNA) director sells 16,000 shares in planned trade - Stock Titan
CareDx (CDNA) director Bickerstaff sells 20,000 shares at $46.285 - Stock Titan
CareDx (CDNA) director sells 44,700 shares, still holds direct and trust stake - Stock Titan
CareDx, Inc. (CDNA) insider sells 2,688 shares under trading plan - Stock Titan
BTIG Research Issues Positive Forecast for CareDx (NASDAQ:CDNA) Stock Price - MarketBeat
Dimensional Fund Advisors LP Has $25.38 Million Stock Position in CareDx, Inc. $CDNA - MarketBeat
Planned 46,963-share sale reported by CDNA insider (CDNA) - Stock Titan
CareDx, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
Price to sales forward of CareDx, Inc. – LS:A118WG - TradingView
CareDx Deadline Alert - TMX Newsfile
CareDx (NASDAQ: CDNA) withholds 2,872 shares for taxes - Stock Titan
CareDx (CDNA) outlines $753,440 planned stock sale via Goldman Sachs - Stock Titan
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
3.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):